Saturday, July 11, 2026

Drug profile · INN

carbon dioide

carbon dioide (CARBON DIOXIDE, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — carbon dioide
US status
approved
Class
Route
INHALATION
Patents
0
Programs
0
Data quality
0.84

Quick answer

carbon dioide (CARBON DIOXIDE, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

Key facts

INN carbon dioide
Brand CARBON DIOXIDE, USP
Route INHALATION
Formulation GAS

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is carbon dioide?

carbon dioide (CARBON DIOXIDE, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

What is the brand name for carbon dioide?

CARBON DIOXIDE, USP is a marketed brand name for carbon dioide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of carbon dioide?

carbon dioide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.